SciencemRNA cancer vaccine reportedly prevents melanoma recurrence in a clinical trial
The Washington Post reports that experts call the result a breakthrough for mRNA-based treatments. It also says vaccine trials for lung and pancreatic cancer are underway.
TLDR
A cancer vaccine succeeded in preventing melanoma recurrence in a clinical trial, The Washington Post reports. The outlet says vaccine trials for lung cancer, pancreatic cancer and other diseases are also underway.
Peter Hotez says his team is developing mRNA vaccines for pancreatic and breast cancer. He hopes to replicate the team's low-cost COVID vaccine effort, which he says reached 100 million people during the pandemic.
mRNA cancer vaccine reportedly prevents melanoma recurrence in a clinical trial
The Washington Post reports that experts call the result a breakthrough for mRNA-based treatments. It also says vaccine trials for lung and pancreatic cancer are underway.